POM Investment Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.6K Sell
48
-177
-79% -$181K 0.07% 80
2026
Q1
$207K Buy
225
+172
+325% +$174K 0.26% 50
2025
Q4
$57.2K Buy
53
+51
+2,550% +$48.8K 0.03% 62
2025
Q3
$1.53K Buy
+2
New +$1.49K ﹤0.01% 171
2025
Q1
– Sell
-186
Closed -$144K – 294
2024
Q4
$144K Hold
186
– – 0.11% 46
2024
Q3
$165K Sell
186
-46
-20% -$41.4K 0.13% 36
2024
Q2
$210K Buy
232
+82
+55% +$65.6K 0.17% 33
2024
Q1
$117K Hold
150
– – 0.1% 45
2023
Q4
$87.4K Buy
+150
New +$87.6K 0.08% 47

Other funds holding LLY

POM Investment Strategies's LLY Position: Q2 2026 in Review

POM Investment Strategies reduced its Eli Lilly (LLY) stake by 79% in Q2 2026, selling an estimated $181K and leaving 48 shares worth $57.6K. The position accounts for 0.07% of the portfolio, ranked #80.

POM Investment Strategies first reported a position in LLY in Q4 2023 and has held it in 9 quarters since. The position peaked at $210K in Q2 2024. 4,647 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • POM Investment Strategies held 48 shares of Eli Lilly worth $57.6K as of Q2 2026.
  • POM Investment Strategies sold 177 Eli Lilly shares in Q2 2026, an estimated $181K.
  • Eli Lilly made up 0.07% of POM Investment Strategies's portfolio in Q2 2026, its #80 holding.
  • POM Investment Strategies first reported a position in Eli Lilly in Q4 2023 and has held it in 9 quarters since.
  • POM Investment Strategies's Eli Lilly position peaked at $210K in Q2 2024.
  • 4,647 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on POM Investment Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.